Meta-analysis shows a link between NAT2 acetylator status and liver injury in patients taking anti-tuberculosis drugs, indicating genetic influence on drug safety.
NAT2 acetylator status was significantly associated with the likelihood of experiencing hepatotoxicity related to anti-tuberculosis drugs.
No takes yet. Share an insight, caveat, or question.
Tavkar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: